ArticleClinical case reports2025
Untying the Next Genetic Thread in a Family With MEN2A Syndrome: A Case Report.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Untying the Next Genetic Thread in a Family With MEN2A Syndrome: A Case Report.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple endocrine neoplasia type 2A (MEN2A) is a rare autosomal dominant syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and primary hyperparathyroidism. Early genetic screening is crucial for timely intervention. We report a familial case of MEN2A involving four affected members across two generations. The index patient, a 40-year-old male with prior MTC and pheochromocytoma, presented with recurrent adrenal disease. His 41-year-old sister was diagnosed with MTC and pheochromocytoma despite negative genetic testing. The youngest sibling (37 years) and the index patient's 18-year-old son were diagnosed with MTC, with the former testing positive for a RET mutation. All underwent appropriate surgeries with ongoing surveillance. This case highlights the variable clinical presentation and genetic penetrance of MEN2A within a single family. It underscores the importance of genetic screening in all MTC patients and their first-degree relatives, as early identification of asymptomatic carriers enables timely prophylactic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.